10:20~11:00 | The past and prospect of atherosclerosis therapy 이상학연세의대 심장내과 |
08:30~08:50 | Triglyceride lowering with pemafibrate to reduce cardiovascular risk 이찬주연세의대 심장내과 | |
08:50~09:10 | Effects of lipoprotein(a) reduction in persons with cardiovascular disease 이은정성균관의대 내분비내과 | |
09:10~09:30 | A comparison of two LDL cholesterol targets after ischemic stroke 김범준울산의대 신경과 | |
09:30~10:00 | Panel discussion |
13:00~13:20 | Pros 이수용부산의대 순환기내과 | |
13:20~13:40 | Cons 한성림서울대 식품영양학과 | |
13:40~13:50 | Rebuttal | |
13:50~14:30 | Panel discussion |
13:00~13:20 | TXNIP serves as a crucial checkpoint in the osteochondrogenic switch of VSMCs in the atherosclerotic milieu 최재훈한양대 생명과학과 | |
13:20~13:40 | Vasoprotective adipokine CTRP9 ameliorates myocardial infarction via histone deacetylase 7 mediated MEF2 activation 하창훈울산의대 융합의학과 | |
13:40~14:00 | A novel pathway to prevent VSMC proliferation in neointimal hyperplasia 김윤학부산의대 해부학교실 | |
14:00~14:30 | Panel discussion |
14:30~14:50 | New, novel lipid lowering agents beyond statins 최성희서울의대 내분비내과 | |
14:50~15:10 | Anti-inflammatory therapy for cardiovascular disease 윤종찬가톨릭의대 순환기내과 | |
15:10~15:30 | Twincretin (GLP-1/GIP dual agonist) for type 2 diabetes and obesity 정창희울산의대 내분비내과 | |
15:30~16:00 | Panel discussion |
14:30~14:50 | CV risk assessment for lipid guidelines: current status & future perspective 이호규연세의대 예방의학교실 | |
14:50~15:10 | Emerging risk factors & biomarkers as cardiovascular risk enhancers 이다영고려의대 내분비내과 | |
15:10~15:30 | Coronary artery calcium score for CV risk reclassification 오진경충남의대 심장내과 | |
15:30~16:00 | Panel discussion |
16:20~16:40 | Pros 정영훈중앙의대 순환기내과 | |
16:40~17:00 | Cons 김신곤고려의대 내분비내과 | |
17:00~17:10 | Rebuttal | |
17:10~17:40 | Panel discussion |
07:30~08:30 | A paradigm shift in dyslipidemia treatment 김병규인제의대 심장내과 |
07:30~08:30 | Optimization of lipid-lowering treatment in patients with type 2 diabetes and dyslipidemia 김혜경연세의대 내분비내과 |
12:00~13:00 | Cutting edge care of pitavastatin with ezetimibe combination therapy 홍준화을지의대 내분비내과 |
12:00~13:00 | Atorvastatin/Ezetimibe treatment for the dyslipidemia in diabetic patients 이용호연세의대 내분비내과 |